MFF Announces New Board of Directors

Judy Jones, Executive Director

Co-founder of the Mycosis Fungoides Foundation.
By profession, Judy is an educator and a licensed professional counselor. Her volunteer work with the Mycosis Fungoides Foundation has become full-time.



Claudia Day, Board Member

Economist, Bureau of Labor Statistics, Washington, D.C. Working on a master's degree in interior design. Former board member on homeowners association. Diagnosed with MF in February, 2000.




Marilyn Eccles, Board Member

AT&T Project/Product Manager for more than 25 years, currently retired. Former board member of the Multiple Sclerosis Foundation in Ft. Lauderdale, Florida.



Dan Goodman, Board Member

Dan Goodman was inspired to take a leadership role in the MFF by his mother, a patient. Dan brings ten years of professional experience in strategic planning to the board. He has also led fundraising efforts for an assisted living facility outside of Kansas City, and for the class fund at his alma mater, Amherst College. Dan currently develops product strategy for America On-line. In his spare time, he volunteers at the National Zoo, and enjoys spending time with his teenage nephews.



Judith Shea, Board Member and Co-founder of MFF

Co-founder of the MFF; retired corporate quality control vice president and real estate professional; mother and grandmother; was a care taker of a Sézary syndrome patient.



Stuart R. Lessin, M.D., Medical Liaison to Medical Advisory Board

Stuart R. Lessin, M.D. is Director of Dermatology at Fox Chase Cancer Center and Chief of the Division of Dermatology at Temple University School of Medicine in Philadelphia, Pennsylvania. He has clinical and research expertise in cutaneous lymphomas.



Dennis DeCola, Industry Advisor

Dennis holds BA and MS degrees in biology. He has spent twenty-eight years with Johnson and Johnson, working in the areas of quality assurance, regulatory affairs, and clinical research. He is now Vice President of Compliance, assuring that company products meet specifications and are in compliance with domestic and foreign government regulations.



Michael Young, Industry Advisor

Michael graduated from Kenyon College and did graduate work at Ohio State University. He is executive Director, Strategic Marketing and Communications, Ligand Pharmaceuticals, Inc., which develops and markets new therapies for cancer and cutaneous diseases. Michael was named Medical Marketer of the Year in 2001, and was recently elected President of the Medical Marketing Association.

English French German Italian Portuguese Russian Spanish

This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.